Literature DB >> 8659787

Dual actions of halothane on intracellular calcium stores of vascular smooth muscle.

T Akata1, W Boyle.   

Abstract

BACKGROUND: Halothane has been reported to affect the integrity of intracellular Ca2+ stores in a number of tissues including vascular smooth muscle. However, the actions of halothane on intracellular Ca2+ stores are not yet fully understood.
METHODS: Employing the isometric tension recording method, the action of halothane in isolated endothelium-denuded rat mesenteric arteries under either intact or beta-escinmembrane-permeabilized conditions was investigated.
RESULTS: Halothane (0.125-5%) produced concentration-dependent contractions in Ca2+ free solution in both intact and membrane-permeabilized muscle strips. Ryanodine treatment or repetitive application of phenylephrine eliminated both caffeine-and halothane-induced contractions in the Ca2+ free solution. When either halothane and caffeine, caffeine and halothane, phenylephrine and halothane, or inositol 1,4,5-triphosphate and halothane were applied consecutively in the Ca2+ free solution in either intact or membrane-permeabilized muscle strips, the contraction induced by application of the second agent of the pair was inhibited compared to application of that agent alone. However, when procaine was applied before and during application of the first agent, the contraction induced by the first agent was inhibited and the contraction induced by the second agent was restored. Heparin inhibited the inositol 1,4,5-triphosphate-mediated contraction, but not contractions induced by halothane or caffeine. Halothane (0.125-5%), applied during Ca2+ loading, produced concentration-dependent inhibition of the caffeine contraction (used to estimate the amount of Ca2+ in the store) in both intact and membrane-permeabilized muscle strips. In contrast, halothane applied with procaine during Ca2+ loading produced concentration-dependent enhancement of the caffeine contraction. This enhancement was observed only in the intact but not in the membrane-permeabilized condition.
CONCLUSIONS: Halothane has two distinct actions on the intracellular Ca2+ stores of vascular smooth muscle, a Ca2+ releasing action and a stimulating action on Ca2+ uptake. Halothane releases Ca2+ from the stores that are sensitive to both caffeine/ryanodine and phenylephrine/inositol 1,4,5-triphosphate through a procaine-sensitive mechanism. The observed inhibitory effect on Ca2+ uptake is probably caused by the Ca2+ uptake after blockade of Ca2+ release may be membrane-mediated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8659787     DOI: 10.1097/00000542-199603000-00014

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

Review 1.  Cellular and molecular mechanisms regulating vascular tone. Part 1: basic mechanisms controlling cytosolic Ca2+ concentration and the Ca2+-dependent regulation of vascular tone.

Authors:  Takashi Akata
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

2.  Effects of halothane on the membrane potential in skeletal muscle of the frog.

Authors:  M P Sauviat; H P Frizelle; A Descorps-Declère; J X Mazoit
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

3.  Effect of hypoxia on parathyroid hormone in lactating and neonatal rats: interaction with halothane.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

4.  PKC independent inhibition of voltage gated calcium channels by volatile anesthetics in freshly isolated vascular myocytes from the aorta.

Authors:  Mohammed Fanchaouy; Luis Cubano; Hector Maldonado; Rostislav Bychkov
Journal:  Cell Calcium       Date:  2013-08-13       Impact factor: 6.817

Review 5.  Anesthetics and Cell-Cell Communication: Potential Ca2+-Calmodulin Role in Gap Junction Channel Gating by Heptanol, Halothane and Isoflurane.

Authors:  Camillo Peracchia
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.